HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension.

Abstract
The interleukin 12 (IL-12) cytokine, encoded by polymorphic genes, plays a central role in the T helper 1 cell-mediated immunity against tumors. We investigated whether the 3' untranslated region +1188 A/C polymorphism (rs 3212227) influences the nasopharyngeal carcinoma (NPC) risk in Tunisian patients. DNA analysis of 247 patients and 284 healthy individuals showed a higher frequency of the 1188 C allele and the CC genotype in patients than in controls (P = 0.00001 and P = 0.00005) suggesting that the C variant allele is associated with the susceptibility to NPC. Additional testing showed that the homozygous CC genotype is also associated with advanced stage of the tumor extension at presentation (P = 0.022). Our data suggest that the impaired production of IL-12 behaves as a risk factor for NPC occurrence and progression.
AuthorsA Ben Chaaben, M Busson, H Douik, W Boukouaci, T Mamoghli, L Chaouch, L Harzallah, S Dorra, C Fortier, A Ghanem, D Charron, R Krishnamoorthy, F Guemira, R Tamouza
JournalTissue antigens (Tissue Antigens) Vol. 78 Issue 2 Pg. 148-51 (Aug 2011) ISSN: 1399-0039 [Electronic] England
PMID21623733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 John Wiley & Sons A/S.
Chemical References
  • Interleukin-12 Subunit p40
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Interleukin-12 Subunit p40 (genetics)
  • Male
  • Middle Aged
  • Models, Statistical
  • Nasopharyngeal Neoplasms (genetics)
  • Neoplasm Metastasis
  • Polymorphism, Genetic
  • Retrospective Studies
  • Risk
  • Sequence Analysis, DNA
  • Tunisia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: